Funder: NIH National Institute of Allergy and Infectious Diseases (NIAID)

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to participate in the NIAID Autoimmunity Centers of Excellence (ACE), a cooperative network intended to improve the understanding, prevention, and treatment of autoimmune diseases. The ACE was founded on the premise that collaborations among basic and clinical scientists can accelerate both fundamental and applied research. The ACE combines Basic and Clinical research programs. This FOA solicits applications for the Basic research program; a companion FOA solicits applications for the Clinical research program. Members of the Basic research program will conduct innovative studies of human autoimmunity within Principal, Pilot, and Collaborative Projects. Members of the Basic and Clinical ACE will work together to design and conduct studies of autoimmune disease pathogenesis and mechanisms of action of immune-modulating interventions being tested in ACE clinical trials.

Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Co-Morbidities, COVID-19, Diabetes, Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Community Engagement, Computational Analysis, Computational or Data Science Methods Development, Epidemiology, Clinical History, Clinical Outcome, Incidence, Risk Factors, Health Disparities, Immunity, Immunology, Host Factors, Prognostics, Virology, Viral Interactome, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Targets, Immunological Response Targets, Anti-viral Targets